Jay Bradner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Uplizna reduces IgG4 related disease flare risk by 87% in MITIGATE trial

The monoclonal antibody Uplizna met key endpoints in a phase 3 trial for the treatment of IgG4-related disease, marking the first time a placebo-controlled study has shown benefit in the condition, according to a press release from Amgen.Topline results from the double-blind, randomized trial, called MITIGATE, demonstrated an 87% reduced risk for IgG4-related disease (IgG4-RD) flare in patients

United statesJay bradnerShenaz baghaZachary wallaceMassachusetts general hospital

Baystreet ca - Advancements in Cancer Therapeutics: What to Expect from the Upcoming 2024 Oncology Conference

USA News Group News Commentary – As the 2024 American Society of Clinical Oncology (ASCO) annual meeting approaches, excitement builds over the latest in cancer treatment advancements, particularly in Antibody-Drug Conjugates (ADCs). From May 31 .

United statesMatt coffeyLevi garrawayJay bradnerThomas heinemanNational cancer instituteMerk co incGlobal product developmentAmgen incGlobal clinical developmentAmerican society of clinical oncologyOncolytics biotechRoche holdingPancreatic cancer action network panMerck research laboratoriesOncolytics biotech inc

USA News Group: Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More

USA News Group: Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesBritish columbiaJay bradnerThomas heinemanLevi garrawayMatt coffeyOncolytics biotechOncolytics biotech incPancreatic cancer action network panAmerican society of clinical oncologyAmgen incMerck research laboratoriesGlobal product developmentUnited states news groupGlobal clinical developmentRoche holding

Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More

Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesBritish columbiaLevi garrawayMatt coffeyJay bradnerThomas heinemanOncolytics biotechOncolytics biotech incPancreatic cancer action network panAmerican society of clinical oncologyAmgen incMerck research laboratoriesGlobal product developmentUnited states news groupGlobal clinical developmentRoche holding

Baystreet ca - Advancements in Cancer Therapeutics: What to Expect from the Upcoming 2024 Oncology Conference

Baystreet ca - Advancements in Cancer Therapeutics: What to Expect from the Upcoming 2024 Oncology Conference
baystreet.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from baystreet.ca Daily Mail and Mail on Sunday newspapers.

United statesMatt coffeyJay bradnerThomas heinemanLevi garrawayMerck research laboratoriesPancreatic cancer action network panGlobal clinical developmentGlobal product developmentOncolytics biotechAmgen incNational cancer instituteMerk co incAmerican society of clinical oncologyOncolytics biotech incRoche holding